Amyloidosis (cont.)
What are symptoms of amyloidosis?
Symptoms in patients with amyloidosis result from abnormal
functioning
of the particular organs involved. The heart, kidneys, liver,
bowels,
skin, nerves, joints, and lungs can be affected. As a result, symptoms are vague and can include fatigue, shortness of breath, weight loss, lack of appetite, numbness, tingling, weakness, enlarged tongue, and swelling. Amyloidosis
affecting the
kidney leads to "nephrotic syndrome," which is
characterized by
severe loss of protein in the urine and swelling of the
extremities.
How is amyloidosis diagnosed?
The diagnosis of amyloidosis is made by detecting the
characteristic
amyloid protein in a biopsy specimen of involved tissue (such
as mouth,
rectum, fat, kidney, heart, or liver). A needle aspiration biopsy of fat just under the skin of the belly (fat pad aspiration), originally developed at Boston University, offers a simple and less invasive method to diagnose systemic amyloidosis. Pathologists can see the protein in the biopsy specimen when it is coated with a special dye, called Congo red stain.
How is amyloidosis treated?
Initial treatment of amyloidosis involves correcting organ failure and
treating
any underlying illness (such as myeloma, infection, or
inflammation). The
disease is frequently
discovered after significant organ damage has already occurred. Therefore, stabilization of organ function is an initial target of treatment.
The most
frequent cause of death in systemic amyloidosis is kidney failure.
Sephardic Jews and Turks inherit a genetic disease called Familial Mediterranean Fever,
which is associated with amyloidosis and
characterized by episodes of "attacks" of fever,
joint, and
abdominal pains. These attacks can be prevented with the
medication
colchicine. Armenians and Ashkenazi Jews also have a higher
incidence of
Familial Mediterranean Fever attacks but do not suffer amyloid
deposition
disease. Other reports of amyloidosis in families are extremely
rare.
Researchers are currently enrolling patients with primary amyloidosis in
clinical trials using a cancer chemotherapy medication (melphalan [Alkeran]), in conjunction with
bone-marrow stem-cells transplantation. The results have been
promising, and this combination treatment is offered to eradicate the amyloidosis in selected patients, provided that the underlying medical condition of the patient is adequate. These aggressive treatment options with stem-cell transplantation and high doses of chemotherapy are a true breakthrough in the treatment of these patients.
Familial amyloidosis can now be cured with liver
transplantation. This option requires an accurate
diagnosis of the
specific protein that causes the disease.
- Amyloidosis is a disorder resulting from abnormal
protein (amyloid) deposits in body tissues.
- Amyloidosis can occur as an isolated disease or as a
result of another illness.
- Symptoms in patients with amyloidosis result from
abnormal functioning of the particular organs involved.
- Diagnosis of amyloidosis is made with a biopsy of
involved tissue.
- Treatment options for amyloidosis depends on the type of amyloidosis and involves correcting organ failure and treating any underlying conditions.
For more information about amyloidosis, please visit the
following site: http://www.bu.edu/amyloid/ (Boston Medical Center).
References: Mayo Clinic Proc. 2006;81(7):880-888.
Mayo Clinic Proc. 2006;81(7):874-876.
Last Editorial Review: 2/1/2008
- colchicine, Colchicine - Read about colchicine, a drug prescribed for the pain of gouty arthritis. Side effects, drug interactions, dosage, and preagnancy information is also included in the information.
- Chemotherapy - Explains chemotherapy, a drug treatment to kill cancer cells. Article includes descriptions, uses, and side effects, and care support.
- Congestive Heart Failure - Read about congestive heart failure symptoms like fatigue, abdomen, leg and ankle swelling, shortness of breath, sleeplessness, increased urination, nausea, abdominal pain, and decreased appetite.
Latest Medical News